{"transactions":[{"id":888238,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-23T16:13:57.000Z","date":"2026-02-19","kind":"grant","planned":false,"acquired":true,"shares":815000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":815000,"derivative":{"exercise_price":2.32,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":815000},"source":{"system":"sec-edgar","filing":"0001628280-26-010616","document":"wk-form4_1771881235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000162828026010616/wk-form4_1771881235.xml","form_type":"4"}},{"id":1116471,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-10T17:26:21.000Z","date":"2025-06-09","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.7008,"value":70080.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":920190,"source":{"system":"sec-edgar","filing":"0001842952-25-000064","document":"wk-form4_1749590774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295225000064/wk-form4_1749590774.xml","form_type":"4"}},{"id":1267575,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-14T16:06:32.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":802700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":802700,"derivative":{"exercise_price":0.81,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":802700},"source":{"system":"sec-edgar","filing":"0001842952-25-000019","document":"wk-form4_1739567178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295225000019/wk-form4_1739567178.xml","form_type":"4"}},{"id":1563566,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-22T08:01:08.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":291402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":291402,"derivative":{"exercise_price":1.07,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":291402},"source":{"system":"sec-edgar","filing":"0001842952-24-000017","document":"wk-form4_1711108859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295224000017/wk-form4_1711108859.xml","form_type":"4"}},{"id":2003838,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-21T20:05:37.000Z","date":"2023-02-21","kind":"purchase","acquired":true,"shares":5823,"price":0.8415,"value":4900.0545,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8154 - $0.8470. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":159701,"source":{"system":"sec-edgar","filing":"0001842952-23-000030","document":"wf-form4_167702790361209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000030/wf-form4_167702790361209.xml","form_type":"4"}},{"id":2016864,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-14T17:04:39.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":287544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":287544,"derivative":{"exercise_price":0.8407,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":287544},"source":{"system":"sec-edgar","filing":"0001842952-23-000027","document":"wf-form4_167641224437732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000027/wf-form4_167641224437732.xml","form_type":"4"}},{"id":2020252,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-13T16:03:23.000Z","date":"2023-02-13","kind":"purchase","acquired":true,"shares":5606,"price":0.8742,"value":4900.7652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8563 - $0.8938. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":153878,"source":{"system":"sec-edgar","filing":"0001842952-23-000020","document":"wf-form4_167632218722654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000020/wf-form4_167632218722654.xml","form_type":"4"}},{"id":2030814,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-06T16:03:09.000Z","date":"2023-02-06","kind":"purchase","acquired":true,"shares":5040,"price":0.9723,"value":4900.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.9449 - $1.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":148272,"source":{"system":"sec-edgar","filing":"0001842952-23-000017","document":"wf-form4_167571737374433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000017/wf-form4_167571737374433.xml","form_type":"4"}},{"id":2042352,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-30T16:03:31.000Z","date":"2023-01-30","kind":"purchase","acquired":true,"shares":7027,"price":0.6974,"value":4900.6298,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.682 - $0.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":143232,"source":{"system":"sec-edgar","filing":"0001842952-23-000012","document":"wf-form4_167511259579472.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000012/wf-form4_167511259579472.xml","form_type":"4"}},{"id":2048801,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-23T17:03:22.000Z","date":"2023-01-23","kind":"purchase","acquired":true,"shares":6839,"price":0.7166,"value":4900.8274,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.7052 - $0.7251. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":136205,"source":{"system":"sec-edgar","filing":"0001842952-23-000008","document":"wf-form4_167451138827052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000008/wf-form4_167451138827052.xml","form_type":"4"}},{"id":2052698,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-18T16:04:19.000Z","date":"2023-01-17","kind":"purchase","acquired":true,"shares":6783,"price":0.7364,"value":4995.0012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":129366,"source":{"system":"sec-edgar","filing":"0001842952-23-000006","document":"wf-form4_167407584583579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295223000006/wf-form4_167407584583579.xml","form_type":"4"}},{"id":2081960,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-12-19T16:11:16.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":20000,"price":0.7398,"value":14796.0,"ownership":{"direct":true},"balance_after":122583,"source":{"system":"sec-edgar","filing":"0001842952-22-000112","document":"wf-form4_167148401293928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000112/wf-form4_167148401293928.xml","form_type":"4"}},{"id":2177087,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-22T16:04:09.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":13000,"price":1.8511,"value":24064.3,"ownership":{"direct":true},"balance_after":102583,"source":{"system":"sec-edgar","filing":"0001842952-22-000081","document":"wf-form4_166119862135485.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000081/wf-form4_166119862135485.xml","form_type":"4"}},{"id":2372429,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-25T16:38:36.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":254300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":254300,"derivative":{"exercise_price":1.79,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":254300},"source":{"system":"sec-edgar","filing":"0001842952-22-000018","document":"wf-form4_164582507420064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295222000018/wf-form4_164582507420064.xml","form_type":"4"}},{"id":2464131,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-20T16:02:00.000Z","date":"2021-12-16","kind":"purchase","acquired":true,"shares":13000,"price":3.2192,"value":41849.6,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":820190,"source":{"system":"sec-edgar","filing":"0001842952-21-000029","document":"wf-form4_164003409890044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000029/wf-form4_164003409890044.xml","form_type":"4"}},{"id":2466637,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Preferred Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":586475,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":1,"derivative":{"underlying":"Common Stock","underlying_shares":586475},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466636,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":210715,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":7,"derivative":{"underlying":"Common Stock","underlying_shares":210715},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466635,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"derivative":{"exercise_price":7.14,"exercise_date":"2020-12-20","expiration_date":"2030-12-20","underlying":"Common Stock","underlying_shares":52680},"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466634,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":807190,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466633,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":586475,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":797190,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466632,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":210715,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":210715,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2466631,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T16:18:34.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":7.14,"value":376135.2,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001842952-21-000027","document":"wf-form4a_163977590040895.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000184295221000027/wf-form4a_163977590040895.xml","form_type":"4/A","original_submission_date":"2021-10-22"}},{"id":2535670,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series Seed Preferred Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":586476,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":586476},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535669,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A Preferred Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":false,"shares":210722,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":210722},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535668,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant (right to buy)","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":0,"derivative":{"exercise_price":7.14,"exercise_date":"2020-12-20","expiration_date":"2030-12-20","underlying":"Common Stock","underlying_shares":52680},"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535667,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":586476,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":849878,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535666,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"exercise","acquired":true,"shares":210722,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":263402,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535665,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"other","acquired":true,"shares":52680,"price":7.14,"value":376135.2,"ownership":{"direct":false,"nature":"Martin Lehr 2000 Trust"},"balance_after":52680,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}},{"id":2535664,"issuer":{"id":7406,"kind":"organization","name":"Context Therapeutics Inc."},"owners":[{"id":65193,"kind":"person","name":"Lehr Martin A.","position":1,"cik":"0001861989","reported_name":"Lehr Martin A.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-10-25T17:30:32.000Z","date":"2021-10-22","kind":"purchase","acquired":true,"shares":10000,"price":5,"value":50000.0,"ownership":{"direct":true},"balance_after":99583,"source":{"system":"sec-edgar","filing":"0001179110-21-009609","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861989/000117911021009609/edgar.xml","form_type":"4"}}]}